- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 32.3M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $18.24K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.11M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.46M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$93.7M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$94.62M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $122.76M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $124.56M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $127.87M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $130.11M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.74M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $12.63M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $32.31M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $33.65M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 149.98K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.54M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$70.17 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$70.17 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $441.9K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.4M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$3.17M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.18M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $2.08M |